APA Citation

Powles, T., Nickles, D., Van Allen, E., Chappey, C., Zou, W., Kowanetz, M., . . . Mariathasan, S. (2015). Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). BioMed Central.

Chicago Style Citation

Powles, Thomas, et al. Immune Biomarkers Associated With Clinical Benefit From Atezolizumab (MPDL3280a; Anti-PD-L1) in Advanced Urothelial Bladder Cancer (UBC). BioMed Central, 2015.

MLA Citation

Powles, Thomas, et al. Immune Biomarkers Associated With Clinical Benefit From Atezolizumab (MPDL3280a; Anti-PD-L1) in Advanced Urothelial Bladder Cancer (UBC). BioMed Central, 2015.

Warning: These citations may not always be 100% accurate.